Observational studyInternational journal of urology : official journal of the Japanese Urological Association2026

Outcomes of Nivolumab-Plus-Ipilimumab in Metastatic Renal Cell Carcinoma: Second Interim Analysis of the J-ENCORE Study.

Tomokazu Sazuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.